Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422786
Status:
COMPLETED
Last Update Posted:
2008-07-15
First Post:
2007-01-12
Brief Title:
Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma
Sponsor:
Thallion Pharmaceuticals
Organization:
Thallion Pharmaceuticals